49 results about "Residual risk" patented technology

Institutional risk is calculated by collecting information about the products and services offered by an institution and assigning a risk value to each product and service. Other aspects and components of an institution are also assigned risk values. The various risk values are calculated along with institutional controls that are in place to mitigate risk in order to determine an overall residual risk assessment for the entity. Forecasts can be made for an institution by adding new or subtracting current business activities and/or institutional controls and calculating an alternative overall residual risk assessment.

A system and method for determining residual business risks by correlating threats, controls, business continuity factors, and other general risk considerations is described. Requirements of an initiative of a project are mapped to a taxonomy, and the mapped requirements are rated with respect to its importance to the project. Projected changes in the mapped requirements are forecasted over a specified period of time, such as an eighteen month period. A threat to the project is mapped to the taxonomy, and the mapped threat is rated with respect to its impact on the project. Projected changes in the effectiveness of the control are forecasted based upon historical data, a maturity rating, and the rated effectiveness of the control. Residual risk associated with the project is then determined, and adjustments to one or more resources associated with the project may be made to reduce the determined residual risk.

The present invention provides pharmacological interventions for the treatment of dyslipidemia, and to the reduction of residual risk of cardiovascular disease and adverse cardiovascular events in patients on intense statin use or with well-controlled LDL-C concentrations. In particular, the invention relates to the use of pemafibrate to prevent cardiovascular events in populations at-risk due to risk factors such as type 2 diabetes mellitus with dyslipidemia in spite of intense statin use or well-controlled LDL-C.

A process for evaluating space systems for safety assurance and residual risk to the flight crew. The process includes a success oriented System Safety phase which attempts to reduce the probability of failure with respect to the loss of a crew member as low as practical; a failure oriented SPACESAFE phase which assumes that at least one Safety Critical Subsystem has failed and attempts to engineer a risk mitigation design minimize adverse effects on the crew; and an Integration phase which complimentary integrates the System Safety phase with the SPACESAFE phase. Such process allows for increased flight crew safety by minimizing risk of a failures that contribute to loss of a crew member.

The invention discloses an industrial control system standard compliance evaluation system, which includes an evaluation module, a topology generation module, an asset management module and a report management module. The beneficial effect of the present invention is: carry out the conformity evaluation of relevant standards to the industrial control system, fully consider the particularity of the industrial control system and the safety requirements of different levels, carefully sort out the assets of the industrial control system system of the unit, and consider the environmental and human factors Analyze the threats faced by the industrial control system, analyze the vulnerability of the industrial control system from the aspects of technology and management, combine the existing security measures, analyze the existing risks of the industrial control system, balance the benefits and costs, formulate a risk treatment plan, and integrate the industrial The residual risk of the control system is controlled at an acceptable level, and the information security strategy is adjusted according to the evaluation results to help industrial enterprises improve their information security protection capabilities.

Systems, methods and products for determining residual values of asset portfolios are disclosed. In one embodiment, a system includes a server computer coupled to a network and to a data storage device. The server generates residual value curves for each of a set of item types and stores them. The server computer also receives and/or maintains information defining a set of items in a portfolio. When an assessment of the portfolio is initiated, the server determines a residual value for each item in the portfolio by identifying a corresponding one of the item types, retrieving the residual value curve corresponding to the identified item type, and determining a future value of the item based on the retrieved residual value curve for the corresponding item type. The server then aggregates the individual residual values into a residual value for the portfolio and enables access to this value.

The invention relates to the field of preparation of bulk pharmaceutical chemicals, in particular to a medicinal calcium folinate. The method comprises the following steps of: firstly reducing folic acid to generate tetrahydrofolic acid; then acylating tetrahydrofolic acid to generate leucovorin hydrochloride; and finally salifying leucovorin hydrochloride to generate calcium folinate. By the adoption of the method, the residual risk of toxic substances in medicines in the traditional process can be avoided completely; nontoxic organic acid zinc is used as a catalyst and nontoxic organic amine carboxylate servers as a reduzate and a protective group of aldehyde group, therefore the product is safer and the yield and purity of the product can be improved; a low-temperature and acidification condition is adopted in the method for keeping the leucovorin hydrochloride which serves as an intermediate stable, therefore the yield of the product can be improved, and impurities in the product can be reduced, and the yield of the finished calcium folinate product, based on calcium folinate, is improved to 30-38% from original 15-20%.

The invention discloses a biodegradable vascular anastomotic device, a special surgical instrument and a method of use thereof, which are used for anastomosis between human blood vessels, between artificial blood vessels, or between human blood vessels and artificial blood vessels. The vascular anastomosis device consists of a The first anastomotic ring/wheel and the second anastomotic ring/wheel are coaxial with each other, and the anastomotic ring/wheel includes a blood vessel support stent, a clamping stent, and anastomotic needles distributed circumferentially at the free end of the vascular support stent. The anastomosis surface of the blood vessel anastomosis device of the present invention has a coaxial geometric structure, the anastomosis is efficient, the anastomosis area is large, the success rate of the operation is improved and the collapse of the anastomotic stoma is reduced. The present invention is made of biodegradable materials. Through reasonable structural design, the vascular anastomotic ring/wheel can be degraded by the human body after operation, and maintain a relatively complete structure during the degradation process. Maintain the corresponding effective support time to maintain the function of the vascular anastomosis ring/wheel, and avoid the risk of foreign body residue caused by traditional mechanical anastomosis methods. The special instrument provided by the invention integrates the functions of clamping and anastomosis, which simplifies the operation process and improves the operation efficiency.

The invention provides a method for preparing edible grade transparent concentrated soybean phospholipid; the Gartner color of the phospholipid obtained by the method is less than 8, the transparency is high, the peroxide value is less than 10 meq/kg, the amount of a residual solvent is less than 50 mg/kg, and indicators meet the requirements of food phospholipid. Soybean crude oil is directly used as raw material, an organic solvent is not required to be added in the preparation process, no residual risk of the organic solvent exists, and at the same time, the potential safety hazard in the production process is reduced. In addition, the method solves the problems of deep color and poor transparency of concentrated soybean phospholipid in China and can realize industrialized production.

A computer-implemented method is provided for valuing and hedging payoffs that are determined by an underlying non-marketed variable that moves randomly. The value assigned is that which is obtained by projecting the instantaneous return of the future payoff onto the span of marketed assets. An explicit method is provided for determining this value by determining a suitable market representative. In a continuous-time embodiment, the methodology is based on an extended Black-Scholes equation that accounts for the correlation between the underlying non-tradable asset and marketed assets. Once this extended equation is solved, the value of the payoff, the optimal hedging strategy, and the residual risk of the optimal hedge can be determined. In alternate embodiments, the same value is determined as the discounted expected value of the payoff, using risk-neutral probabilities for the non-marketed variable. These risk-neutral probabilities are again determined by the relation of the underlying variable to the payoff of a most-correlated marketed asset. The risk-neutral version of the method applies in both continuous-time and discrete-time frameworks, providing asset valuation, optimal hedging, and evaluation of the minimum residual risk after hedging.

Methods, computer-readable media, and apparatuses are disclosed for quantifying risk and control assessments. The risk includes both residual risk and direction of risk. Various aspects of the invention quantitatively compare the risk and control assessments against step-ahead losses using special regression models that are particularly applicable to this kind of data. The empirical comparison may be performed on both loss event frequency and severity in two different and separate dimensions. The empirical comparison may also be performed using losses extracted by even occurrence and event settlement dates in two separate dates.

The invention relates to a barrier coating film without a prime coat and a preparation method thereof. By improving barrier coating liquid, a PVOH product having better barrier performance is added inPVDC latex, barrier performance (less than or equal to 2cc/m<2>, 24 hr) is increased, a polymerization technology is adjusted, the barrier coating film without the prime coat is finally prepared, under prerequisite that obstruct effect is good, a film prime coating process is reduced, an organic solvent generated during production can be avoided, and residual risk of a product solvent cannot be generated.

Establishing a vendor profile may comprise identifying a plurality of risk elements associated with a vendor that supplies one or more products to an entity. Any completed management actions for the vendor that mitigate risk associated with any of the identified risk elements are identified. A performance requirement for the vendor associated with at least one of the products supplied by the vendor to the entity is identified. A performance measurement for the identified performance requirement for the vendor is identified. A residual risk for at least one of the identified risk elements is determined according to a completed management action that reduces risk associated with the at least one of the identified risk elements. A performance level is determined according to the performance requirement and the performance measurement. A vendor profile is created according to the identified risk elements, completed management actions, identified performance requirements, and performance measurement.

A system for interest rate risk management, comprising: an input device, configured to receive as input a first group of data indicative of a first group of financial instruments to be protected; a second group of data indicative of a second group of financial instruments aimed at protecting said first group of financial instruments; and an interest rate risk minimization device, connected to said input device, configured to receive as input said first and second group of data, a data feed of current market prices of said first and second group of financial instruments, a set of parameters of a term structure model, and historical zero-coupon term structures of interest rates, and to generate historical model errors and, considering these errors, the optimal amount to be invested in each financial instrument which shall be used to protect the balance sheet or portfolio. The interest rate risk minimization device is further configured to generate a residual risk estimation.

The invention relates to an application of an edible fungus extract in preparing a preparation for treating and/ or preventing liver injury related diseases caused by a high fat diet, in particular toan application of a red mushroom extract in preparing a preparation for treating and/ or preventing liver injury related diseases caused by a high fat diet. The preparation method is simple and feasible, and low in operation cost; and an extraction solvent in the preparation method can be recycled, the residual risk of an organic reagent is avoided, the natural quality of the red mushroom extractis ensured, and the red mushroom extract is environment-friendly, and the method belongs to a green manufacturing technology. According to the invention, the raw materials are completely extracted, the raw materials are fully utilized, and the utilization rate of the raw materials is high on the basis of ensuring the effect of the extract. The red mushroom extract shows obvious treatment and/ orprevention effects on liver injury related diseases, for example, the red mushroom extract can effectively relieve the deterioration of inflammation and improve various physiological and pathologicalindexes related to immunity, can be used in various fields such as medicines, health care products and the like, and has great economic and social values.

The invention relates to a use of an edible fungus extract in preparing a preparation for treating and/or preventing intestinal flora disorder and related diseases, in particular to a use of a russuleextract in preparing a preparation for treating and/or preventing the intestinal flora disorder and related diseases. The preparation method is simple and easy to implement and low in operation cost;and an extraction solvent in the preparation method can be recycled, so that the residual risk of an organic reagent is avoided, the natural quality of the ressule extract is ensured, the preparationmethod is environment-friendly, and the preparation method belongs to a green manufacturing technology. According to the invention, the raw materials are completely extracted, the raw materials are fully utilized, and the utilization rate of the raw materials is high. The russule extract not only can obviously contribute to the recovery of the dominant flora structure in a intestinal tract and the diversity of the flora, but also has obvious treatment and/or prevention effects on diseases related to the flora structure of the intestinal tract, can be used in various fields such as medicines,health care products and the like, and has great economic and social values.

The invention discloses a detection method of a flumequine chiral enantiomer in seawater. The method is characterized by comprising the following steps: taking 80-110mL of aquaculture seawater and adding in a beaker, adding 1mg-2mg of flumequine standard substance, performing ultrasonic treatment to completely dissolve the flumequine standard substance, taking 3-5mL of the obtained solution, treating by an HLB solid-phase extraction column, leaching by using 4-6mL of deionized water, and then eluting by using 5-10mL of methanol; nitrogen-blowing the eluent to nearly dry, redissolving by using ethanol, metering volume to 3mL, filtering by a millipore filter membrane with size of 0.22-0.45 micron to obtain a solution A; using n-hexane and ethanol in volume ratio of (10-40): (60-90) as a mobile phase, and adding methanoic acid with volume content of 0.1%-0.3% and ammonium acetate aqueous solution (5mmol/L) in the mobile phase to separate the flumequine chiral enantiomer; detecting the solution A by using high performance liquid chromatograph, wherein a CHIRALCEL OD-H chiral column is adopted, the column temperature is the room temperature, the flow velocity is 0.5mL/min to 0.7mL/min, and the wavelength is 254nm. By adopting the method disclosed by the invention, the flumequine chiral enantiomer can be successfully separated so that the residual quantity of the flumequine chiral enantiomer in the seawater can be detected, and basis is provided for the residual risk assessment and reasonable and safe use of flumequine in the seawater aquaculture.

A detecting method for trichlorfon enantiomers in culture pond bottom mud includes the steps that a bottom mud sample is placed into a centrifugal tube, anhydrous sodium sulfate is added to remove water, acetic acid is added to acidize acetonitrile, centrifuging is performed after ultrasonic extraction is performed, an upper layer extracting solution is taken into a flask, the extracting process is repeated 2-3 times, extracting solutions are mixed, the mixed solution is subjected to rotary evaporation and concentration in a water bath at 27 DEG C, a concentrated solution is added into CARB/NH2 cartridges activated in advance, the acetonitrile is used for flushing the flask, flushing liquid passes through the CARB/NH2 cartridges, outflow liquid is collected, and the CARB/NH2 cartridges are blown through nitrogen to be almost dry, hexyl hydride/isopropanol is used for performing redissolving and volume constancy on the liquid to 1 mL, and then the liquid passes through a microporous filtering film of 0.22 micrometer to obtain a solution A; with the hexyl hydride/isopropanol being a moving phase, separation is performed on the trichlorfon enantiomers; a high-performance liquid chromatograph is used for detecting the solution A, (as shown in specifications) IC chiral columns are selected for usage, the temperature of the columns is 25 DEG C, the flow rate is 1 mL/min, and the wavelength is 207 nm. The trichlorfon chiral enantimoers can be successfully separated, in this way, the residual quantity of the trichlorfon enantiomers in the bottom mud is detected, and bases are provided for residual risk estimation and reasonable and safe using of trichlorfon in bottom mud culture.

The invention belongs to the field of the bacterial disease control and prevention of the aquatic livestock, and relates to a usage of baicalin for preparing pharmaceuticals for preventing and treating aquatic livestock streptococcicosis, and discloses a usage of the baicalin for inhibiting activity of tilapia-sourced streptococcus agalactiae Beta-hemolysis/cytolysin. The baicalin is applied for preparing the pharmaceuticals for preventing and treating the bacteriosis of aquatic culture animals, especially the prevention and control pharmaceuticals for tilapia streptococcus diseases, and the pharmaceuticals have the remarkable curative effect. The baicalin is a flavonoid active ingredient extracted and separated from dried roots of dicotyledonous labiate scutellaria baicalensis, and is developed as a new drug for preventing and treating the tilapia-sourced streptococcus. The baicalin has the advantages of abundant sources, low cost, low drug resistance probability, low residual risk, small toxic and side effect, environment-friendliness, no pollution, no harm and remarkable curative effect, and has the extensive application prospect.

The invention discloses an urban public safety evaluation method based on risk and capability, which divides urban public safety evaluation into four stages of existing risk evaluation, residual risk evaluation, emergency capability evaluation and urban public safety evaluation. The method considers the inhibition effect of the capability on the risk and the comprehensive influence effect of the capability and the risk on the urban public safety, carries out the existing risk evaluation, screens major risk event scenes, evaluates the residual risk in combination with the prevention and control capability, analyzes the scene task, evaluates the emergency capability, and carries out the safety evaluation based on the staggered influence of the risk and the capability. And comprehensively evaluating the urban public safety level. According to the embodiment of the invention, different management perspectives and different evaluation perspectives of the urban public safety are effectively fused, the inhibition effect of the capability on the risk and the comprehensive influence effect of the risk and the capability on the urban public safety are reflected, and systematic analysis and comprehensive evaluation of the urban public safety can be realized.

The invention belongs to the field of an evaluation technology of environmental pollution treatment, and relates to a leaching and residual risk evaluation technology of chelate-induced phytoremediation in heavy-metal contaminated soil. The technology provided by the invention is characterized by overlapping two pots up and down to simulate the soil at different depths, planting plants and analyzing the soil sample to precisely and conveniently evaluate a residual effect caused by using a chelating agent and the leaching risk on the soil on the lower layer. The design provided by the invention is capable of overcoming shortcomings of destructive sampling of traditional soil column experiments, conveniently simulating the soil on the deep layer to plant the plants and perform sample analysis. The invention provides a direct and reliable evaluation method for evaluating the residual effect of the chelating agent and the leaching risk in the chelate-induced phytoremediation process.

A system for interest rate risk management, comprising: an input device, configured to receive as input a first group of data indicative of a first group of financial instruments to be protected; a second group of data indicative of a second group of financial instruments aimed at protecting said first group of financial instruments; and an interest rate risk minimization device, connected to said input device, configured to receive as input said first and second group of data, a data feed of current market prices of said first and second group of financial instruments, a set of parameters of a term structure model, and historical zero-coupon term structures of interest rates, and to generate historical model errors and, considering these errors, the optimal amount to be invested in each financial instrument which shall be used to protect the balance sheet or portfolio. The interest rate risk minimization device is further configured to generate a residual risk estimation.